Tag Archives: European Commission

Europe: Whatever Happened to Faster Reimbursement for Generics?

The plan to accelerate generic pricing and reimbursement has become another tragic European casualty, writes Brussels correspondent Reflector.
Posted in Europe, Op-Ed, pricing, Regulatory | Also tagged , , , , | Leave a comment

Europe's Mooted 'Passport for Physicians': Implications for Patients

Europe moved one step closer to a passport for physicians in early October. The European Parliament gave its backing to creating a virtual professional qualifications card that will allow doctors, pharmacists, and other professionals to practice in another EU country. The system also envisages an alert system, so that health professionals barred in one country […]
Posted in Europe, Global, Guest Blog, Strategy | Also tagged , , , , | Leave a comment

European Pharma Gears Up for Horizon 2020

European Pharma Gears Up for Horizon 2020 The ink is not yet dry on the European Union’s Horizon 2020 agreement to invest some €70 billion ($92 bn) in research over the next seven years, and already contenders for funding are jostling for attention. Europe’s biggest drug industry association EFPIA scored something of a coup by […]
Posted in Europe, Global, Guest Blog, Op-Ed | Also tagged , , , , , | Leave a comment

Europe: Countdown Time for the Innovative Medicines Initiative?

Momentum is gathering in Brussels for real battles over carving up the 1 trillion dollars that the European Union has now agreed to spend between the end of this year and the end of the decade. The constituencies jostling for funding include farmers and foreign aid workers, teachers and train operators, and legislators and local […]
Posted in Global, Guest Blog | Also tagged , , , , | Leave a comment

Europe: Is National Drug Pricing Freedom Nearing its Expiry Date?

By Reflector, Brussels correspondent. For more than fifty years the basic European Union rules about medicines have been clear. Each member country is free to decide the prices that medicines are sold at in its territory, and what reimbursement should be provided for it. But an observer of the European Parliament discussions in February wouldn’t […]
Posted in Strategy | Also tagged , , , | Leave a comment
  • Categories

  • Meta